10
Views
130
CrossRef citations to date
0
Altmetric
Gene Expression

Identification of a Unique Core Domain of Par-4 Sufficient for Selective Apoptosis Induction in Cancer Cells

, , , &
Pages 5516-5525 | Received 31 Dec 2002, Accepted 19 May 2003, Published online: 27 Mar 2023

REFERENCES

  • Barradas, M., A. Monjas, M. T. Diaz-Meco, M. Serrano, and J. Moscat. 1999. The downregulation of the proapoptotic protein Par-4 is critical for Ras-induced survival and tumor progression. EMBO J. 18: 6362–6369.
  • Berra, E., M. M. Municio, L. Sanz, S. Frutos, M. T. Diaz-Meco, and J. Moscat. 1997. Positioning atypical protein kinase C isoforms in the UV-induced apoptotic signaling cascade. Mol. Cell. Biol. 17: 4346–4354.
  • Boghaert, E. R., S. F. Sells, A. J. Walid, P. Malone, N. M. Williams, M. H. Weinstein, R. Strange, and V. M. Rangnekar. 1997. Immunohistochemical analysis of the proapoptotic protein Par-4 in normal rat tissues. Cell Growth Differ. 8: 881–890.
  • Boldin, M. P., E. E. Varfolomeev, Z. Pancer, I. L. Mett, J. H. Camonis, and D. Wallach. 1995. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270: 7795–7798.
  • Chakraborty, M., S. G. Qiu, K. M. Vasudevan, and V. M. Rangnekar. 2001. Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression. Cancer Res. 61: 7255–7263.
  • Chang, S., J. H. Kim, and J. Shin. 2002. p62 forms a ternary complex with protein kinase Czeta and PAR-4 and antagonizes PAR- 4-induced protein kinase Czeta inhibition. FEBS Lett. 510: 57–61.
  • Cheema, S. K., S. K. Mishra, V. M. Rangnekar, A. M. Tari, R. Kumar, and G. Berestein. 2003. PAR-4 transcriptionally regulates Bcl-2 through a WT1 binding site on the bcl-2 promoter. J. Biol. Chem. 278: 19995–20005.
  • Cook, J., S. Krishnan, S. Ananth, S. F. Sells, Y. Shi, M. M. Walther, W. M. Linehan, V. P. Sukhatme, M. H. Weinstein, and V. M. Rangnekar. 1999. Decreased expression of the proapoptotic protein Par-4 in renal cell carcinoma. Oncogene 18: 1205–1208.
  • Culmsee, C., Y. Zhu, J. Krieglstein, and M. P. Mattson. 2001. Evidence for the involvement of Par-4 in ischemic neuron cell death. J. Cereb. Blood Flow Metab. 21: 334–343.
  • de Thonel, A., A. Bettaieb, C. Jean, G. Laurent, and A. Quillet-Mary. 2001. Role of protein kinase C zeta isoform in Fas resistance of immature myeloid KG1a leukemic cells. Blood 98: 3770–3777.
  • Diaz-Meco, M. T., M. J. Lallena, A. Monjas, S. Frutos, and J. Moscat. 1999. Inactivation of the inhibitory kappaB protein kinase/nuclear factor kappaB pathway by Par-4 expression potentiates tumor necrosis factor alpha-induced apoptosis. J. Biol. Chem. 274: 19606–19612.
  • Diaz-Meco, M. T., M. M. Municio, S. Frutos, P. Sanchez, J. Lozano, L. Sanz, and J. Moscat. 1996. The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C. Cell 86: 777–786.
  • Duan, W., Z. Guo, and M. P. Mattson. 2000. Participation of par-4 in the degeneration of striatal neurons induced by metabolic compromise with 3-nitropropionic acid. Exp. Neurol. 165: 1–11.
  • Duan, W., V. M. Rangnekar, and M. P. Mattson. 1999. Prostate apoptosis response-4 production in synaptic compartments following apoptotic and excitotoxic insults: evidence for a pivotal role in mitochondrial dysfunction and neuronal degeneration. J. Neurochem. 72: 2312–2322.
  • Dutta, K., A. Alexandrov, H. Huang, and S. M. Pascal. 2001. pH-induced folding of an apoptotic coiled coil. Protein Sci. 10: 2531–2540.
  • El-Guendy, N., and V. M. Rangnekar. 2003. Apoptosis by Par-4 in cancer and neurodegenerative diseases. Exp. Cell Res. 283: 51–66.
  • Guo, Q., W. Fu, J. Xie, H. Luo, S. F. Sells, J. W. Geddes, V. Bondada, V. M. Rangnekar, and M. P. Mattson. 1998. Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease. Nat. Med. 4: 957–962.
  • Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell 100: 57–70.
  • Itoh, N., and S. Nagata. 1993. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J. Biol. Chem. 268: 10932–10937.
  • Johnstone, R. W., A. A. Ruefli, and S. W. Lowe. 2002. Apoptosis: a link between cancer genetics and chemotherapy. Cell 108: 153–164.
  • Johnstone, R. W., R. H. See, S. F. Sells, J. Wang, S. Muthukkumar, C. Englert, D. A. Haber, J. D. Licht, S. P. Sugrue, T. Roberts, V. M. Rangnekar, and Y. Shi. 1996. A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1. Mol. Cell. Biol. 16: 6945–6956.
  • Johnstone, R. W., N. Tommerup, C. Hansen, H. Vissing, and Y. Shi. 1998. Mapping of the human PAWR (par-4) gene to chromosome 12q21. Genomics 53: 241–243.
  • Kimura, M., T. Furukawa, T. Abe, T. Yatsuoka, E. M. Youssef, T. Yokoyama, H. Ouyang, Y. Ohnishi, M. Sunamura, M. Kobari, S. Matsuno, and A. Horii. 1998. Identification of two common regions of allelic loss in chromosome arm 12q in human pancreatic cancer. Cancer Res. 58: 2456–2460.
  • Kischkel, F. C., S. Hellbardt, I. Behrmann, M. Germer, M. Pawlita, P. H. Krammer, and M. E. Peter. 1995. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14: 5579–5588.
  • Mayo, M. W., C. Y. Wang, P. C. Cogswell, K. S. Rogers-Graham, S. W. Lowe, C. J. Der, and A. S. Baldwin, Jr. 1997. Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 278: 1812–1815.
  • Nalca, A., S. G. Qiu, N. El-Guendy, S. Krishnan, and V. M. Rangnekar. 1999. Oncogenic Ras sensitizes cells to apoptosis by Par-4. J. Biol. Chem. 274: 29976–29983.
  • Page, G., D. Kogel, V. Rangnekar, and K. H. Scheidtmann. 1999. Interaction partners of Dlk/ZIP kinase: coexpression of Dlk/ZIP kinase and Par-4 results in cytoplasmic retention and apoptosis. Oncogene 18: 7265–7273.
  • Pedersen, W. A., H. Luo, I. Kruman, E. Kasarskis, and M. P. Mattson. 2000. The prostate apoptosis response-4 protein participates in motor neuron degeneration in amyotrophic lateral sclerosis. FASEB J. 14: 913–924.
  • Peter, M. E., and P. H. Krammer. 1998. Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr. Opin. Immunol. 10: 545–551.
  • Rayet, B., and C. Gelinas. 1999. Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18: 6938–6947.
  • Sells, S. F., S. S. Han, S. Muthukkumar, N. Maddiwar, R. Johnstone, E. Boghaert, D. Gillis, G. Liu, P. Nair, S. Monnig, P. Collini, M. P. Mattson, V. P. Sukhatme, S. G. Zimmer, D. P. Wood, Jr., J. W. McRoberts, Y. Shi, and V. M. Rangnekar. 1997. Expression and function of the leucine zipper protein Par-4 in apoptosis. Mol. Cell. Biol. 17: 3823–3832.
  • Sells, S. F., D. P. Wood, Jr., S. S. Joshi-Barve, S. Muthukumar, R. J. Jacob, S. A. Crist, S. Humphreys, and V. M. Rangnekar. 1994. Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells. Cell Growth Differ. 5: 457–466.
  • Tartaglia, L. A., T. M. Ayres, G. H. Wong, and D. V. Goeddel. 1993. A novel domain within the 55 kd tumor necrosis factor receptor signals cell death. Cell 74: 845–853.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.